.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Quality Drugs has demonstrated a fluctuating performance in the Edible category within the state of Oregon. In April 2025, the brand held a commendable 8th position, which slightly dipped to 9th in May, further declining to 11th in June. However, a modest recovery was observed in July, with the brand climbing back to the 10th position. This movement indicates a competitive landscape in Oregon's Edible market, where Quality Drugs faces both challenges and opportunities for growth. Despite these rank fluctuations, the brand's ability to maintain a position within the top 15 highlights its resilience and potential to regain a stronger foothold in the coming months.
Sales figures for Quality Drugs in Oregon's Edible category reflect a downward trend from April to June, with a notable decrease from $184,312 in April to $133,368 in June. However, July saw a slight rebound, with sales increasing to $141,335. This trend suggests that while the brand experienced a dip in consumer demand during the early summer months, there was a partial recovery as the season progressed. The absence of Quality Drugs from the top 30 in other states or categories could be seen as a potential area for expansion or improvement, indicating that the brand's current focus might be heavily centered on Oregon's Edible market.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs has experienced notable fluctuations in its rank and sales over the period from April to July 2025. Initially ranked 8th in April, Quality Drugs saw a decline to 11th place by June, before slightly recovering to 10th in July. This period of volatility in rank is mirrored in its sales, which decreased significantly from April to June, before a modest uptick in July. In contrast, Private Stash maintained a consistent 8th place rank throughout the same period, with sales peaking in June, indicating a stable and potentially growing customer base. Meanwhile, Hapy Kitchen held steady at 10th place for three months before dropping to 11th in July, with a consistent decline in sales, suggesting potential challenges in maintaining market share. Botz showed a remarkable recovery from 15th place in May to 9th in June and July, with sales reflecting this upward trend. The dynamic shifts in rankings and sales among these brands highlight the competitive pressures Quality Drugs faces, emphasizing the need for strategic marketing and product innovation to regain and sustain its market position.
Notable Products
In July 2025, Cosmic Pop Gummy (100mg) maintained its position as the top-performing product for Quality Drugs, continuing its streak at rank 1 with notable sales of 4,567. Assorted Fruit Chews 10-Pack (100mg) improved its position from rank 3 in June to rank 2 in July, indicating a positive trend. Super Sour Apple Gummy (100mg) climbed back to rank 3 after dropping to rank 4 in June. Assorted Caramels 10-Pack (100mg) made its debut in the rankings at position 4, showing promising sales figures. Meanwhile, Watermelon Gummy (100mg) consistently held the 5th position, despite a slight decrease in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
